Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism
ConditionThyroid Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAarhus University Hospital
About this trial
The study aims to test if use of autofluorescence imaging (AF) reduces the risk of developing hypoparathyroidism (hypoPT) following surgery for thyroid cancer, either total thyroidectomy (TT) or completion hemithyroidectomy (cHT).
Eligibility criteria
Qualifiers
Age>18 years and able to give informed consent.
Suspicion or diagnosis of thyroid cancer.
Planned total thyroidectomy or completion thyroidectomy.
Normocalcemia prior to surgery.
Disqualifiers
Planned simultaneous parathyroid surgery.
Treatment with active vitamin D analogues.
eGFR < 30.
Trial design
Treatments tested in this trial
- Surgery with autofluorescence
Treatment groups
160 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov